Cagrilintide · Metabolic
Cagrilintide dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (160 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 100–135 mcg | 0.10–0.14 mL | 4–5 units0.04–0.05 mL | — |
| 60–75 kg / 132–165 lb | 122–166 mcg | 0.12–0.17 mL | 5–7 units0.05–0.07 mL | — |
| 75–90 kg / 165–198 lb | 150–202 mcg | 0.15–0.20 mL | 6–8 units0.06–0.08 mL | — |
| 90–105 kg / 198–231 lb | 177–239 mcg | 0.18–0.24 mL | 7–10 units0.07–0.10 mL | — |
| >105 kg / >231 lb | 204–276 mcg | 0.20–0.28 mL | 8–11 units0.08–0.11 mL | — |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Cagrilintide; the elapsed-time column is hidden.
Cagrilintide by goal
Read Cagrilintide's profile and dosing through a specific research-goal lens.
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.